Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             217 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Absorption-promoting adjuvants: enhancing action on rectal absorption Nishihata, Toshiaki
 1997
 163-164 2 p. 205-228
24 p.
 artikel
2 A case for prodrugs: Fosphenytoin Stella, Valentino J.
 1996
 163-164 2 p. 311-330
20 p.
 artikel
3 Advancements in immune tolerance Pan, Ping-Ying
 2008
 163-164 2 p. 91-105
15 p.
 artikel
4 Advances in targeted delivery Pouton, Colin W
 2001
 163-164 2 p. 133-134
2 p.
 artikel
5 Amperometric enzyme biosensors for the analysis of drugs and metabolites Harwood, G.W.John
 1996
 163-164 2 p. 163-191
29 p.
 artikel
6 Announcement 1989
 163-164 2 p. 277-
1 p.
 artikel
7 Announcement from the publishers 1991
 163-164 2 p. iii-
1 p.
 artikel
8 Antibody structure and antibody engineering Tan, Lee K.
 1988
 163-164 2 p. 129-142
14 p.
 artikel
9 Antisense oligonucleotide therapeutics: drug delivery and targeting Rojanasakul, Yongyut
 1996
 163-164 2 p. 115-131
17 p.
 artikel
10 Antisense strategies in degenerative joint diseases: Sense or nonsense? Huber, Lars C.
 2006
 163-164 2 p. 285-299
15 p.
 artikel
11 Application of numerical methods for diffusion-based modeling of skin permeation Frasch, H. Frederick
 2013
 163-164 2 p. 208-220
13 p.
 artikel
12 Are there predictors of Remicade treatment success or failure? Su, Chinyu
 2005
 163-164 2 p. 237-245
9 p.
 artikel
13 Arginine containing peptides as delivery vectors Tung, Ching-Hsuan
 2003
 163-164 2 p. 281-294
14 p.
 artikel
14 ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects Park, Yoon-Jeong
 2003
 163-164 2 p. 251-265
15 p.
 artikel
15 Bacterial pore-forming hemolysins and their use in the cytosolic delivery of macromolecules Provoda, Chester J
 2000
 163-164 2 p. 209-221
13 p.
 artikel
16 Barrier properties of mucus Cone, Richard A.
 2009
 163-164 2 p. 75-85
11 p.
 artikel
17 Beta-cell replacement for insulin-dependent diabetes mellitus Efrat, Shimon
 2008
 163-164 2 p. 114-123
10 p.
 artikel
18 Beyond oncology — Application of HPMA copolymers in non-cancerous diseases Liu, Xin-Ming
 2010
 163-164 2 p. 258-271
14 p.
 artikel
19 Biocompatibility of biomaterials: hemocompatibility, immunocompatiblity and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers Říhová, Blanka
 1996
 163-164 2 p. 157-176
20 p.
 artikel
20 Bioconjugates for effective drug targeting 2003
 163-164 2 p. 169-170
2 p.
 artikel
21 Biodegradable soluble macromolecules as drug carriers Drobník, Jaroslav
 1989
 163-164 2 p. 229-245
17 p.
 artikel
22 Biologics in development for rheumatoid arthritis: Relevance to osteoarthritis Abramson, Steven B.
 2006
 163-164 2 p. 212-225
14 p.
 artikel
23 Biomaterials for stem cell differentiation Dawson, Eileen
 2008
 163-164 2 p. 215-228
14 p.
 artikel
24 Biomimetic materials for tissue engineering Ma, Peter X.
 2008
 163-164 2 p. 184-198
15 p.
 artikel
25 Bioreductive and gene therapy approaches to hypoxic diseases Jaffar, Mohammed
 2001
 163-164 2 p. 217-228
12 p.
 artikel
26 Biosensing and drug delivery at the microscale Siegel, Ronald A.
 2004
 163-164 2 p. 121-123
3 p.
 artikel
27 Biosynthetic polyhydroxyalkanoates and their potential in drug delivery Pouton, Colin W.
 1996
 163-164 2 p. 133-162
30 p.
 artikel
28 Bispecific antibody conjugates in therapeutics Cao, Ying
 2003
 163-164 2 p. 171-197
27 p.
 artikel
29 Block copolymer micelles as drug delivery systems 2002
 163-164 2 p. 167-
1 p.
 artikel
30 Block copolymer micelles for delivery of gene and related compounds Kakizawa, Yoshinori
 2002
 163-164 2 p. 203-222
20 p.
 artikel
31 Breaching the skin barrier — Insights from molecular simulation of model membranes Notman, Rebecca
 2013
 163-164 2 p. 237-250
14 p.
 artikel
32 Cartilage tissue engineering for degenerative joint disease Nesic, Dobrila
 2006
 163-164 2 p. 300-322
23 p.
 artikel
33 Catabolism of therapeutic proteins and peptides with implications for drug delivery Bocci, Velio
 1989
 163-164 2 p. 149-169
21 p.
 artikel
34 Cell-based drug delivery Pierigè, F.
 2008
 163-164 2 p. 286-295
10 p.
 artikel
35 Cell sheet engineering for heart tissue repair Masuda, Shinako
 2008
 163-164 2 p. 277-285
9 p.
 artikel
36 Cell therapy for spinal cord regeneration Willerth, Stephanie M.
 2008
 163-164 2 p. 263-276
14 p.
 artikel
37 Cellular and biochemical interactions of macromolecular drug delivery systems Artursson, Per
 1989
 163-164 2 p. 165-189
25 p.
 artikel
38 Cellular delivery of peptide nucleic acid (PNA) Koppelhus, Uffe
 2003
 163-164 2 p. 267-280
14 p.
 artikel
39 Cellular events in the uptake and degradation of hyaluronan Smedsrød, Bård
 1991
 163-164 2 p. 265-278
14 p.
 artikel
40 Challenges and emerging technologies in the immunoisolation of cells and tissues Wilson, John T.
 2008
 163-164 2 p. 124-145
22 p.
 artikel
41 Chemically modified chitosans as enzyme inhibitors Bernkop-Schnürch, Andreas
 2001
 163-164 2 p. 127-137
11 p.
 artikel
42 Chitosan for mucosal vaccination van der Lubben, I.M
 2001
 163-164 2 p. 139-144
6 p.
 artikel
43 Chitosans for gene delivery Borchard, Gerrit
 2001
 163-164 2 p. 145-150
6 p.
 artikel
44 Clearance of hyaluronan from the circulation Lebel, Lena
 1991
 163-164 2 p. 221-235
15 p.
 artikel
45 Closed-loop insulin delivery—the path to physiological glucose control Steil, G.M
 2004
 163-164 2 p. 125-144
20 p.
 artikel
46 Conditional gene targeting for cancer gene therapy Haviv, Yosef S.
 2001
 163-164 2 p. 135-154
20 p.
 artikel
47 Controlled differentiation of stem cells Hwang, Nathaniel S.
 2008
 163-164 2 p. 199-214
16 p.
 artikel
48 Controlled drug delivery in tissue engineering Biondi, Marco
 2008
 163-164 2 p. 229-242
14 p.
 artikel
49 Critical appraisal of the in vitro immunization technology for the production of mouse and human monoclonal antibodies Borrebaeck, Carl A.K.
 1988
 163-164 2 p. 143-165
23 p.
 artikel
50 Cyclodextrins in oligonucleotide delivery Redenti, Enrico
 2001
 163-164 2 p. 235-244
10 p.
 artikel
51 Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells Rao, Mangala
 2000
 163-164 2 p. 171-188
18 p.
 artikel
52 Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure Dancik, Yuri
 2013
 163-164 2 p. 221-236
16 p.
 artikel
53 Detailed modeling of skin penetration—An overview Naegel, Arne
 2013
 163-164 2 p. 191-207
17 p.
 artikel
54 Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities Duncan, Ruth
 2010
 163-164 2 p. 272-282
11 p.
 artikel
55 Drug and gene delivery to mucosal tissues: the mucus barrier Hanes, Justin
 2009
 163-164 2 p. 73-74
2 p.
 artikel
56 Drug delivery in advancing the treatment of inflammatory bowel disease 2005
 163-164 2 p. 215-216
2 p.
 artikel
57 Drug delivery in degenerative joint disease Aigner, Thomas
 2006
 163-164 2 p. 123-124
2 p.
 artikel
58 Drug delivery in degenerative joint disease: Where we are and where to go? Abramson, Steven
 2006
 163-164 2 p. 125-127
3 p.
 artikel
59 Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities Saito, Go
 2003
 163-164 2 p. 199-215
17 p.
 artikel
60 Drug delivery systems using hyaluronan and its derivatives Larsen, Nancy E.
 1991
 163-164 2 p. 279-293
15 p.
 artikel
61 Drug delivery to mitochondria: the key to mitochondrial medicine Murphy, Michael P
 2000
 163-164 2 p. 235-250
16 p.
 artikel
62 Drug targeting to hypoxic tissue using self-inactivating bioreductive delivery systems Naughton, D.P
 2001
 163-164 2 p. 229-233
5 p.
 artikel
63 Editorial Lévy, Raphaël
 2012
 163-164 2 p. 127-128
2 p.
 artikel
64 Editorial Board 2009
 163-164 2 p. ii-
1 p.
 artikel
65 Editorial Board 2010
 163-164 2 p. ii-
1 p.
 artikel
66 Editorial Board 2013
 163-164 2 p. ii-
1 p.
 artikel
67 Editorial Board 2003
 163-164 2 p. ii-
1 p.
 artikel
68 Editorial Board 2006
 163-164 2 p. ii-
1 p.
 artikel
69 Editorial Board 2004
 163-164 2 p. ii-
1 p.
 artikel
70 Editorial Board 2008
 163-164 2 p. ii-
1 p.
 artikel
71 Editorial Board 2005
 163-164 2 p. ii-
1 p.
 artikel
72 Editorial Board 2012
 163-164 2 p. ii-
1 p.
 artikel
73 Effective drug delivery by PEGylated drug conjugates Greenwald, Richard B.
 2003
 163-164 2 p. 217-250
34 p.
 artikel
74 Electronic MEMS for triggered delivery Richards Grayson, Amy C.
 2004
 163-164 2 p. 173-184
12 p.
 artikel
75 Emerging trends in cell-based therapies Ye, Zhaoyang
 2008
 163-164 2 p. 89-90
2 p.
 artikel
76 Endosomes, lysosomes: their implication in gene transfer Wattiaux, Robert
 2000
 163-164 2 p. 201-208
8 p.
 artikel
77 Endothelial cell biology and culture methods for drug transport studies Angelis, Elena De
 1996
 163-164 2 p. 193-218
26 p.
 artikel
78 Engineering cartilage tissue Chung, Cindy
 2008
 163-164 2 p. 243-262
20 p.
 artikel
79 Enzyme immobilization in liquid surfactant membrane emulsions Scheper, Thomas
 1989
 163-164 2 p. 209-231
23 p.
 artikel
80 Erratum 1991
 163-164 2 p. 311-
1 p.
 artikel
81 Extracellular barriers in respiratory gene therapy Sanders, Niek
 2009
 163-164 2 p. 115-127
13 p.
 artikel
82 Ex vivo gene therapy approaches to cartilage repair Gelse, K.
 2006
 163-164 2 p. 259-284
26 p.
 artikel
83 Finite and infinite dosing: Difficulties in measurements, evaluations and predictions Selzer, Dominik
 2013
 163-164 2 p. 278-294
17 p.
 artikel
84 Flow control with hydrogels Eddington, David T.
 2004
 163-164 2 p. 199-210
12 p.
 artikel
85 Forthcoming event 1991
 163-164 2 p. 234-
1 p.
 artikel
86 Forthcoming events 1996
 163-164 2 p. 269-270
2 p.
 artikel
87 Forthcoming Events 1991
 163-164 2 p. 309-310
2 p.
 artikel
88 Forthcoming events 1995
 163-164 2 p. 205-206
2 p.
 artikel
89 Gene therapeutic approaches—transfer in vivo Evans, C.H.
 2006
 163-164 2 p. 243-258
16 p.
 artikel
90 Genetic modification of cells for transplantation Lai, Yi
 2008
 163-164 2 p. 146-159
14 p.
 artikel
91 Genetic modification of stem cells for transplantation Phillips, M. Ian
 2008
 163-164 2 p. 160-172
13 p.
 artikel
92 Gene transfection and lymphocyte immortalization: a new approach to human monoclonal antibody production Jonak, Z.L.
 1988
 163-164 2 p. 207-228
22 p.
 artikel
93 Gene-transfer systems for human endothelial cells Martin, S.G
 2000
 163-164 2 p. 223-233
11 p.
 artikel
94 Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy Griesenbach, Uta
 2009
 163-164 2 p. 128-139
12 p.
 artikel
95 Gold nanorods: Their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions Alkilany, Alaaldin M.
 2012
 163-164 2 p. 190-199
10 p.
 artikel
96 Guide to Authors 2004
 163-164 2 p. 231-234
4 p.
 artikel
97 Guide to Authors 2005
 163-164 2 p. 317-320
4 p.
 artikel
98 Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery Ziaie, Babak
 2004
 163-164 2 p. 145-172
28 p.
 artikel
99 Hepatic first-pass effect and controlled drug delivery following rectal administration de Boer, A.G.
 1997
 163-164 2 p. 229-237
9 p.
 artikel
100 Hormone containing growth promoting implants in farmed livestock Preston, R.L.
 1999
 163-164 2 p. 123-138
16 p.
 artikel
101 HPMA copolymer–cyclic RGD conjugates for tumor targeting Pike, Daniel B.
 2010
 163-164 2 p. 167-183
17 p.
 artikel
102 HPMA copolymers for masking and retargeting of therapeutic viruses Fisher, Kerry D.
 2010
 163-164 2 p. 240-245
6 p.
 artikel
103 HPMA copolymers for modulating cellular signaling and overcoming multidrug resistance Minko, Tamara
 2010
 163-164 2 p. 192-202
11 p.
 artikel
104 HPMA copolymers: Origins, early developments, present, and future Kopeček, Jindřich
 2010
 163-164 2 p. 122-149
28 p.
 artikel
105 HPMA copolymers: 30years of advances Lammers, Twan
 2010
 163-164 2 p. 119-121
3 p.
 artikel
106 Hyaluronan-binding proteins and receptors Turley, Eva A.
 1991
 163-164 2 p. 257-264
8 p.
 artikel
107 Hyaluronan in drug delivery Drobnik, Jaroslav
 1991
 163-164 2 p. 295-308
14 p.
 artikel
108 Immunogenicity and immunomodulatory properties of HPMA-based polymers Říhová, Blanka
 2010
 163-164 2 p. 184-191
8 p.
 artikel
109 Immunotherapy with dendritic cells for cancer Ballestrero, Alberto
 2008
 163-164 2 p. 173-183
11 p.
 artikel
110 Improved input parameters for diffusion models of skin absorption Hansen, Steffi
 2013
 163-164 2 p. 251-264
14 p.
 artikel
111 Improved oral drug delivery: solubility limitations overcome by the use of prodrugs Fleisher, David
 1996
 163-164 2 p. 115-130
16 p.
 artikel
112 Improved passive oral drug delivery via prodrugs Taylor, Michael D.
 1996
 163-164 2 p. 131-148
18 p.
 artikel
113 Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations Lammers, Twan
 2010
 163-164 2 p. 203-230
28 p.
 artikel
114 Induction of immune tolerance to facilitate β cell regeneration in type 1 diabetes Pasquali, Lorenzo
 2008
 163-164 2 p. 106-113
8 p.
 artikel
115 Integrated microsystems for controlled drug delivery Zafar Razzacki, S.
 2004
 163-164 2 p. 185-198
14 p.
 artikel
116 Intraarticular drug delivery in osteoarthritis Gerwin, Nicole
 2006
 163-164 2 p. 226-242
17 p.
 artikel
117 Intrauterine administration of peptide drugs for systemic effect Golomb, G.
 1995
 163-164 2 p. 179-190
12 p.
 artikel
118 Intrauterine contraceptive device — status report Chi, I-cheng
 1995
 163-164 2 p. 165-178
14 p.
 artikel
119 Key issues in the purification and characterization of recombinant proteins for therapeutic use Sharma, Satish K.
 1989
 163-164 2 p. 87-111
25 p.
 artikel
120 Lessons from nature: “Pathogen-Mimetic” systems for mucosal Nano-medicines Mrsny, Randall J.
 2009
 163-164 2 p. 172-192
21 p.
 artikel
121 Lipophilic prodrugs designed for intestinal lymphatic transport Charman, William N.
 1996
 163-164 2 p. 149-169
21 p.
 artikel
122 Long-acting control of ectoparasites: a review of collar technologies for companion animals Witchey-Lakshmanan, Leonore C
 1999
 163-164 2 p. 113-122
10 p.
 artikel
123 Luminescent quantum dots as platforms for probing in vitro and in vivo biological processes Mattoussi, Hedi
 2012
 163-164 2 p. 138-166
29 p.
 artikel
124 Lymphatic delivery in ‘rectal drug delivery systems’ Yoshikawa, Hiroshi
 1997
 163-164 2 p. 239-251
13 p.
 artikel
125 Lysosome membrane permeability: implications for drug delivery Lloyd, John B
 2000
 163-164 2 p. 189-200
12 p.
 artikel
126 Macromolecular systems for chemotherapy and magnetic resonance imaging Matthews, Susan E.
 1996
 163-164 2 p. 219-267
49 p.
 artikel
127 Mathematical and pharmacokinetic modelling of epidermal and dermal transport processes Anissimov, Yuri G.
 2013
 163-164 2 p. 169-190
22 p.
 artikel
128 Mathematical modeling of molecular diffusion through mucus Cu, Yen
 2009
 163-164 2 p. 101-114
14 p.
 artikel
129 Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier Gratieri, Taís
 2013
 163-164 2 p. 315-329
15 p.
 artikel
130 Mesalamine delivery systems: do they really make much difference? Qureshi, Altamash I.
 2005
 163-164 2 p. 281-302
22 p.
 artikel
131 Micelles based on HPMA copolymers Talelli, M.
 2010
 163-164 2 p. 231-239
9 p.
 artikel
132 Micro- and macrorheology of mucus Lai, Samuel K.
 2009
 163-164 2 p. 86-100
15 p.
 artikel
133 Micromachined biocapsules for cell-based sensing and delivery Leoni, Lara
 2004
 163-164 2 p. 211-229
19 p.
 artikel
134 Modeling the human skin barrier — Towards a better understanding of dermal absorption Jepps, Owen G.
 2013
 163-164 2 p. 152-168
17 p.
 artikel
135 Modeling the human skin barrier—Towards a better understanding of dermal absorption Hansen, Steffi
 2013
 163-164 2 p. 149-151
3 p.
 artikel
136 Modern drug delivery applications of chitosan 2001
 163-164 2 p. 103-
1 p.
 artikel
137 Molecular imaging of HPMA copolymers: Visualizing drug delivery in cell, mouse and man Lu, Zheng-Rong
 2010
 163-164 2 p. 246-257
12 p.
 artikel
138 Monolayer coated gold nanoparticles for delivery applications Rana, Subinoy
 2012
 163-164 2 p. 200-216
17 p.
 artikel
139 Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Lai, Samuel K.
 2009
 163-164 2 p. 158-171
14 p.
 artikel
140 Nanoparticles for nasal vaccination Csaba, Noemi
 2009
 163-164 2 p. 140-157
18 p.
 artikel
141 New adjuvants for vaccines containing purified protein antigens Eppstein, Deborah A.
 1989
 163-164 2 p. 233-253
21 p.
 artikel
142 New biologically active fragments of immunoglobulins Chipens, Gunar
 1988
 163-164 2 p. 167-206
40 p.
 artikel
143 New oral delivery systems for treatment of inflammatory bowel disease Friend, David R.
 2005
 163-164 2 p. 247-265
19 p.
 artikel
144 NLS bioconjugates for targeting therapeutic genes to the nucleus Escriou, Virginie
 2003
 163-164 2 p. 295-306
12 p.
 artikel
145 Oral drug absorption enhancement by chitosan and its derivatives Thanou, M
 2001
 163-164 2 p. 117-126
10 p.
 artikel
146 Oral treatment options for degenerative joint disease—presence and future Steinmeyer, Jürgen
 2006
 163-164 2 p. 168-211
44 p.
 artikel
147 Osmotic delivery of peptides and macromolecules Amkraut, A.
 1989
 163-164 2 p. 255-276
22 p.
 artikel
148 Osteoarthritis Buckwalter, Joseph A.
 2006
 163-164 2 p. 150-167
18 p.
 artikel
149 Osteoarthritis: Pathobiology—targets and ways for therapeutic intervention Aigner, T.
 2006
 163-164 2 p. 128-149
22 p.
 artikel
150 Pathophysiology and treatment of pain in joint disease Schaible, Hans-Georg
 2006
 163-164 2 p. 323-342
20 p.
 artikel
151 PEG-based micelles as carriers of contrast agents for different imaging modalities Torchilin, Vladimir P
 2002
 163-164 2 p. 235-252
18 p.
 artikel
152 Penetration and enzymatic barriers to peptide and protein absorption Lee, Vincent H.L.
 1989
 163-164 2 p. 171-207
37 p.
 artikel
153 Peptide drug delivery: Colonic and rectal absorption Mackay, Martin
 1997
 163-164 2 p. 253-273
21 p.
 artikel
154 Pharmacokinetic and pharmacodynamic aspects of site-specific drug delivery Boddy, Alan
 1989
 163-164 2 p. 155-163
9 p.
 artikel
155 Pharmacokinetic evaluation of polymeric carriers Nishikawa, Makiya
 1996
 163-164 2 p. 135-155
21 p.
 artikel
156 Pharmacokinetics and pharmacodynamics of trans-endometrial administered peptides and macromolecules Huffman, A.
 1995
 163-164 2 p. 191-203
13 p.
 artikel
157 Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution Dufort, Sandrine
 2012
 163-164 2 p. 179-189
11 p.
 artikel
158 Physiology of the colorectal barrier Edwards, Christine
 1997
 163-164 2 p. 173-190
18 p.
 artikel
159 Pluronic® block copolymers: novel functional molecules for gene therapy Kabanov, Alexander V
 2002
 163-164 2 p. 223-233
11 p.
 artikel
160 Polyether–polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations Liggins, R.T.
 2002
 163-164 2 p. 191-202
12 p.
 artikel
161 Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery Lavasanifar, Afsaneh
 2002
 163-164 2 p. 169-190
22 p.
 artikel
162 Polymeric micelles as new drug carriers Kwon, Glen S.
 1996
 163-164 2 p. 107-116
10 p.
 artikel
163 Polymer-modified proteins: preclinical development and regulatory strategies Hoyle, Peter C.
 1991
 163-164 2 p. 219-233
15 p.
 artikel
164 Predicting skin permeability from complex vehicles Karadzovska, Daniela
 2013
 163-164 2 p. 265-277
13 p.
 artikel
165 Predicting the absorption of chemical vapours Rauma, Matias
 2013
 163-164 2 p. 306-314
9 p.
 artikel
166 Preface Golomb, G.
 1995
 163-164 2 p. 149-150
2 p.
 artikel
167 Preface Muranishi, Shozo
 1997
 163-164 2 p. 171-
1 p.
 artikel
168 Preface Stella, Valentino J.
 1996
 163-164 2 p. 111-114
4 p.
 artikel
169 Preface Rathbone, Michael J
 1999
 163-164 2 p. 111-
1 p.
 artikel
170 Preface Goddard, Peter
 1991
 163-164 2 p. V-VI
nvt p.
 artikel
171 Preface Drobník, J.
 1991
 163-164 2 p. v-
1 p.
 artikel
172 Preface Tomlinson, Eric
 1988
 163-164 2 p. iii-iv
nvt p.
 artikel
173 Preface Tomlinson, E.
 1989
 163-164 2 p. iii-
1 p.
 artikel
174 Preface Petrak, K.
 1989
 163-164 2 p. iii-
1 p.
 artikel
175 Preparation, in vivo properties and proposed clinical use of polyoxyethylene-modified tissue plasminogen activator and streptokinase Pizzo, S.V.
 1991
 163-164 2 p. 153-166
14 p.
 artikel
176 Prodrugs and targeted drug delivery Kearney, Albert S.
 1996
 163-164 2 p. 225-239
15 p.
 artikel
177 Prodrugs for improved CNS delivery Anderson, Bradley D.
 1996
 163-164 2 p. 171-202
32 p.
 artikel
178 Prodrugs for improved ocular drug delivery Järvinen, Tomi
 1996
 163-164 2 p. 203-224
22 p.
 artikel
179 Prodrugs of anticancer agents Sinhababu, Achintya K.
 1996
 163-164 2 p. 241-273
33 p.
 artikel
180 Prodrugs of peptides and peptidomimetics for improved formulation and delivery Oliyai, Reza
 1996
 163-164 2 p. 275-286
12 p.
 artikel
181 Prodrugs of phosphates, phosphonates, and phosphinates Krise, Jeffrey P.
 1996
 163-164 2 p. 287-310
24 p.
 artikel
182 Properties of asparaginase-dextran conjugates Wileman, Thomas E.
 1991
 163-164 2 p. 167-180
14 p.
 artikel
183 Pulsatile release from subcutaneous implants Medlicott, Natalie J
 1999
 163-164 2 p. 139-149
11 p.
 artikel
184 Quantum dots to tail single bio-molecules inside living cells Pierobon, Paolo
 2012
 163-164 2 p. 167-178
12 p.
 artikel
185 Recent advances in cellular, sub-cellular and molecular targeting Moghimi, S.M
 2000
 163-164 2 p. 129-133
5 p.
 artikel
186 Recent advances in predicting skin permeability of hydrophilic solutes Chen, Longjian
 2013
 163-164 2 p. 295-305
11 p.
 artikel
187 Recent advances in the analysis of peptides and proteins by mass spectrometry Carr, Steven A.
 1989
 163-164 2 p. 113-147
35 p.
 artikel
188 Receptor-mediated targeting of toxins to intraerythrocytic parasite Plasmodium falciparum Surolia, Namita
 2000
 163-164 2 p. 163-170
8 p.
 artikel
189 Rectal drug delivery systems Improvement of rectal peptide absorption by absorption enhancers, protease inhibitors and chemical modification Yamamoto, Akira
 1997
 163-164 2 p. 275-299
25 p.
 artikel
190 Regulation of intestinal epithelial function: a link between opportunities for macromolecular drug delivery and inflammatory bowel disease Siccardi, Dario
 2005
 163-164 2 p. 219-235
17 p.
 artikel
191 SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy Maeda, Hiroshi
 1991
 163-164 2 p. 181-202
22 p.
 artikel
192 Soluble macromolecular carriers for the delivery of antitumour drugs Sezaki, Hitoshi
 1989
 163-164 2 p. 247-266
20 p.
 artikel
193 Somatotropin delivery to farmed animals Foster, Todd P
 1999
 163-164 2 p. 151-165
15 p.
 artikel
194 Structural and chemical aspects of HPMA copolymers as drug carriers Ulbrich, Karel
 2010
 163-164 2 p. 150-166
17 p.
 artikel
195 Suppression of antibody responses by conjugates of antigens and monomethoxypoly(ethylene glycol) Sehon, Alec H.
 1991
 163-164 2 p. 203-217
15 p.
 artikel
196 Targetable drug carriers: present status and a future perspective Yokoyama, Masayuki
 1996
 163-164 2 p. 77-80
4 p.
 artikel
197 Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide Fedorak, Richard N.
 2005
 163-164 2 p. 303-316
14 p.
 artikel
198 Targeted drug conjugates: principles and progress Garnett, Martin C
 2001
 163-164 2 p. 171-216
46 p.
 artikel
199 Targeted drug delivery via the folate receptor Sudimack, Jennifer
 2000
 163-164 2 p. 147-162
16 p.
 artikel
200 Targeting gene expression using HSV vectors Burton, Edward A
 2001
 163-164 2 p. 155-170
16 p.
 artikel
201 The crucial role of spacer groups in macromolecular prodrug design Soyez, Heidi
 1996
 163-164 2 p. 81-106
26 p.
 artikel
202 Theory and practice of site-specific drug delivery Tomlinson, E.
 1987
 163-164 2 p. 87-198
112 p.
 artikel
203 Therapeutic opportunities for targeted liposomal drug delivery Allen, Theresa M.
 1996
 163-164 2 p. 117-133
17 p.
 artikel
204 Therapeutic proteins — a pharmaceutical perspective Goddard, Peter
 1991
 163-164 2 p. 103-131
29 p.
 artikel
205 The therapeutic value of poly(ethylene glycol)-modified proteins Nucci, Mary L.
 1991
 163-164 2 p. 133-151
19 p.
 artikel
206 Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease Klotz, Ulrich
 2005
 163-164 2 p. 267-279
13 p.
 artikel
207 Topical formulations and wound healing applications of chitosan Ueno, Hiroshi
 2001
 163-164 2 p. 105-115
11 p.
 artikel
208 Toxicology of nanoparticles Elsaesser, Andreas
 2012
 163-164 2 p. 129-137
9 p.
 artikel
209 Transcellular and paracellular contribution to transport processes in the colorectal route Hayashi, Masahiro
 1997
 163-164 2 p. 191-204
14 p.
 artikel
210 Transport of macromolecules across the capillary walls Petrak, Karel
 1989
 163-164 2 p. 191-214
24 p.
 artikel
211 Transport of proteins through the membranes of the adult gastro-intestinal tract — a potential for drug delivery? Pusztai, A.
 1989
 163-164 2 p. 215-228
14 p.
 artikel
212 Treatment targets in inflammatory bowel disease Sellin, Joseph
 2005
 163-164 2 p. 217-218
2 p.
 artikel
213 Tuftsin-bearing liposomes in treatment of macrophage-based infections Agrawal, Ajay K
 2000
 163-164 2 p. 135-146
12 p.
 artikel
214 Turnover of hyaluronan in the tissues Laurent, Ulla B.G.
 1991
 163-164 2 p. 237-256
20 p.
 artikel
215 Twelfth International Symposium On Recent Advances in Drug Delivery Systems 2005
 163-164 2 p. I-
1 p.
 artikel
216 Uterine biology and the intrauterine device Elchalal, U.
 1995
 163-164 2 p. 151-164
14 p.
 artikel
217 Vaccine delivery to animals Bowersock, Terry L
 1999
 163-164 2 p. 167-194
28 p.
 artikel
                             217 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland